Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

MLA

Aris Liakos, et al. “Efficacy and Safety of Once-Weekly Glucagon-like Peptide 1 Receptor Agonists for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetes, Obesity and Metabolism, vol. 17, Sept. 2015, pp. 1065–74. EBSCOhost, https://doi.org/10.1111/dom.12541.

APA

Aris Liakos, Apostolos Tsapas, Despoina Vasilakou, Thomas Karagiannis, David R. Matthews, Paschalis Paschos, Maria Rika, Maria Mainou, Panagiota Boura, Eleni Athanasiadou, & Eleni Bekiari. (2015). Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism, 17, 1065–1074. https://doi.org/10.1111/dom.12541

Chicago

Aris Liakos, Apostolos Tsapas, Despoina Vasilakou, Thomas Karagiannis, David R. Matthews, Paschalis Paschos, Maria Rika, et al. 2015. “Efficacy and Safety of Once-Weekly Glucagon-like Peptide 1 Receptor Agonists for the Management of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” Diabetes, Obesity and Metabolism 17 (September): 1065–74. doi:10.1111/dom.12541.